We recently updated our Privacy Notice and Terms of Use.
Med-IQ

Course Listings: Hematology

All Results (8)
Format: Live Events (1) Online Activities (7)

Challenges in Disease Management for Type 1 Gaucher Disease

View Course

Format: Live Event

Maximum Credits: 4.5

Course Description: This live meeting will improve clinician’s knowledge of the variable presentation of GD1 in children, adolescents and adults in order to facilitate earlier diagnosis and determine appropriate management. Clinicians will also discuss genetic testing and prenatal and newborn screening and review the importance of counseling patients with GD1 that are planning to…More


Advances in Breast Cancer

View Course

Format: Webcast

Maximum Credits: 0.5

Course Description: This 30-minute webcast reviews recent updates and current clinical evidence in breast cancer management, including the latest surgical techniques, the use of genomic medicine in HR+/HER2- early stage breast cancer, and radiotherapy fractionation for early stage breast cancer.


Advances in the Management of Brain Metastases

View Course

Format: Webcast

Maximum Credits: 0.5

Course Description: In this 30-minute webcast, expert faculty review recent advances in the management of brain malignancies. In particular, April K.S. Salama, MD, discusses the current understanding of systemic therapy, John Kirkpatrick, MD, PhD, discusses advances in radiation therapy, and Peter Fecci, MD, PhD, discusses surgical improvements for brain metastasis.


Recent Advances in the Treatment of Hematologic Malignancies

View Course

Format: Webcast

Maximum Credits: 0.5

Course Description: In this 30-minute webcast, expert faculty explore recent advances in the treatment of hematologic malignancies. In particular, CAR T-cell therapy for relapsed and refractory diffuse large B-cell lymphoma and FLT3-targeted treatment in AML are discussed.


GFR and eGFR: Filtering Out the Confusion

View Course

Format: E-Publication

Maximum Credits: 1.0

Course Description: Nephrologist Dr. Michael Wiederkehr delves into chronic kidney disease (CKD) and the difference between true glomerular filtration rate (GFR) and estimated glomerular filtration rate (eGFR). The different methods of calculating eGFR will be explored as well as the pitfalls and limitations of the current formulas and calculations. The importance of the CKD…More


Decision-IQ: Assessing Risk and Preventing Tumor Lysis Syndrome

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: This brief case-based, digital CME activity incorporates current evidence-based prophylaxis algorithms to assess the risk of tumor lysis syndrome (TLS) in a patient with chronic lymphocytic leukemia (CLL) undergoing anticancer therapy. Links to relevant literature and expert insights are provided to help clinicians prevent and manage TLS.


Raising the Bar in NHL Through the Provision of Shared Decision Making

View Course

Format: E-Publication

Maximum Credits: 0.5

Course Description: This 30-minute, interactive digital publication interweaves clinical patient cases as well as patient, caregiver, and clinician insights from national surveys to examine the role of shared decision making in non-Hodgkin lymphoma. Evidence-based guideline recommendations for managing patients with follicular lymphoma and diffuse large B-cell lymphoma, as well as…More


The Rapidly Evolving Role of Biosimilars: Educating Specialists and Facilitating Shared Decision Making With Patients

View Course

Format: E-Publication

Maximum Credits: 0.75

Course Description: This accredited CME publication describes biosimilars and how they compare with their originator products, reviews FDA guidance on the biosimilar approval process, and discusses key issues for prescribers. In addition, brief clinical case vignettes present examples of how biosimilars may appear in practice.